Banque Populaire Rives de Paris

Up&Charge is a company that specializes in automated induction charging stations, providing a wireless charging solution for electric vehicles. Its technology enables cable-free charging through an induction system, allowing users to recharge their vehicles without the need for physical connections. The self-service charging stations are designed for round-the-clock availability, ensuring convenience for clients. Additionally, Up&Charge's approach preserves sidewalk space, making it a practical option for urban environments. The automated recharging capability allows for remote activation via an application, further enhancing user experience and accessibility.

Ray Studios is a Tattoo removal studio that employs hydraulic acoustic wave technology in its "Le Ray Spark" Tattoo removal treatment device.

Groupe Flo SA is a prominent player in the restaurant industry, with operations in France and internationally. Founded in 1968 and based in Courbevoie, France, the company manages a diverse portfolio of dining establishments. It operates 178 restaurants, including 91 owned and 87 franchised, featuring well-known brands such as Hippopotamus, Maître Kanter's Taverne, and Bistro Romain. In addition to its restaurant operations, Groupe Flo also runs 25 breweries, including notable venues like Le Vaudeville, Bofinger, and La Coupole. The company further extends its reach through concession operations, managing 13 locations at prestigious sites such as Disneyland Paris and Jardin des Plantes.

Dianosic SAS is a healthcare organization based in Strasbourg, France, founded in 2017. The company specializes in the development of advanced medical devices aimed at addressing Ear, Nose, and Throat (ENT) conditions. Dianosic's flagship products include CAVI-T, an asymmetrical intranasal balloon that effectively manages spontaneous or postoperative bleeding through low-pressure compression while adapting to the nasal cavity's unique anatomy. Additionally, the company has developed an Active Resorbable Intranasal Scaffold device designed to treat chronic sinusitis and allergic rhinitis, particularly for patients who have not responded to conventional drug treatments. This innovative scaffold is characterized by its long-acting formulation, which allows for sustained drug release over a period of six to twelve months. Dianosic aims to set new standards of care in ENT treatment, with the potential to expand its technology into other areas such as chronic migraine and facial pain management.